ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Program Get Shot In Arm With Override Of Appropriations Vet; Carter To Leave NCI

February 6, 1976

GM To Offer Three Awards of $1000,000 Each To Cancer Investigators

September 8, 1978

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

December 4, 1981

U.S. Breast Cancer Death Rate Declines.

September 28, 2007

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005